In vivo animal studies showed similar results that stable FOXA2 knockdown significantly facilitated the anti‐cancer role of OXA, as evidenced by the smaller tumor size, growth rates, and tumor weights (Figure S5A‐C, Supporting Information). The gene discussed is FOXA2; the disease is neoplasm.